These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2830550)

  • 21. The direct effect of reserpine in vitro on prolactin release from rat anterior pituitary glands.
    Login IS; MacLeod RM
    Brain Res; 1981 Jan; 204(1):79-85. PubMed ID: 7248756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic stimulation of pituitary but not hypothalamic estrogen receptors in ovariectomized rats.
    Carrillo AJ; Steger RW; Chamness GC
    Endocrinology; 1983 May; 112(5):1839-46. PubMed ID: 6131816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine.
    Canonico PL; Valdenegro CA; MacLeod RM
    Endocrinology; 1983 Jul; 113(1):7-14. PubMed ID: 6861715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Met5]enkephalin concentrations in rat pituitary are maintained under opioid inhibition.
    George SR; Kertesz M
    Eur J Pharmacol; 1987 Aug; 140(1):95-8. PubMed ID: 3622625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine receptor activation inhibits estrogen-stimulated transforming growth factor-alpha gene expression and growth in anterior pituitary, but not in uterus.
    Borgundvaag B; Kudlow JE; Mueller SG; George SR
    Endocrinology; 1992 Jun; 130(6):3453-8. PubMed ID: 1534540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopaminergic system modulation of nociceptive response in long-term diabetic rats.
    Rutledge LP; Ngong JM; Kuperberg JM; Samaan SS; Soliman KF; Kolta MG
    Pharmacol Biochem Behav; 2002 Dec; 74(1):1-9. PubMed ID: 12376147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
    Hoffmann IS; Talmaciu RK; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine and bromocriptine inhibit cyclic AMP accumulation in the anterior pituitary: the effect of cholera toxin.
    Cronin MJ; Thorner MO
    J Cyclic Nucleotide Res; 1982; 8(4):267-75. PubMed ID: 6300209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of striatal enkephalinergic neurons by antipsychotic drugs.
    Hong JS; Yoshikawa K; Kanamatsu T; Sabol SL
    Fed Proc; 1985 Jun; 44(9):2535-9. PubMed ID: 3838946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corticosterone response induced by intracerebroventricular administration of met-enkephalin and naloxone in rats under stress.
    Gadek-Michalska A; Cetera B; Bugajski J
    Folia Med Cracov; 1997; 38(3-4):17-26. PubMed ID: 10481378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of pimozide and bromocriptine on anterior pituitary cell proliferation.
    Stepień H; Wolaniuk A; Pawlikowski M
    J Neural Transm; 1978; 42(3):239-44. PubMed ID: 690630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphofunctional study of mammotropic cells following intraventricular administration of met-enkephalin.
    Carretero J; Sánchez F; Blanco E; Riesco JM; Sánchez-Franco F; Vázquez R
    Anat Embryol (Berl); 1989; 179(3):243-50. PubMed ID: 2916748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic regulation of glandular kallikrein in the intermediate lobe of the rat pituitary.
    Powers CA
    Neuroendocrinology; 1986; 43(3):368-76. PubMed ID: 3637674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of chlordecone administration on brain and pituitary peptide systems.
    Hong JS; Hudson PM; Yoshikawa K; Ali SF; Mason GA
    Neurotoxicology; 1985; 6(1):167-82. PubMed ID: 2581193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metorphamide levels in chromaffin cells increase after treatment with reserpine.
    Eiden LE; Zamir N
    J Neurochem; 1986 May; 46(5):1651-4. PubMed ID: 3958720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in [Met5]- and [Leu5]enkephalin and neurotensin content in basal ganglia induced by the long-term administration of dopamine agonist and antagonist drugs to rats.
    De Ceballos ML; Boyce S; Jenner P; Marsden CD
    Eur J Pharmacol; 1986 Nov; 130(3):305-9. PubMed ID: 3792452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of yohimbine on rat prolactin secretion.
    Meltzer HY; Simonovic M; Gudelsky GA
    J Pharmacol Exp Ther; 1983 Jan; 224(1):21-7. PubMed ID: 6294278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphometrical variations of prolactin cells in response to prolonged and systemic administration of Met-enkephalin in female rats.
    Carretero J; Blanco E; Sánchez F; Riesco JM; Rubio M; Juanes JA; Vázquez R
    Anat Embryol (Berl); 1992; 186(1):99-105. PubMed ID: 1514707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopaminergic modulation of the diethylstilbestrol-induced proliferation of the anterior pituitary gland of the Fisher 344 rat.
    Miyazaki K; Dambrosia JM; Kebabian JW
    Neuroendocrinology; 1985 Nov; 41(5):405-8. PubMed ID: 2932654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attenuation of anterior pituitary phosphoinositide phosphorylase activity by the D2 dopamine receptor.
    Jarvis WD; Judd AM; MacLeod RM
    Endocrinology; 1988 Dec; 123(6):2793-9. PubMed ID: 2904359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.